Investigating how salt inducible kinases affect parathyroid hormone's role in bone health
The role of salt inducible kinases in parathyroid hormone action in bone
This study is looking at how a hormone called parathyroid hormone helps build bones, especially for older adults with osteoporosis, and it aims to find a way to create new oral medications that can boost bone growth without needing daily shots.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11086841 on NIH RePORTER |
What this research studies
This research focuses on understanding how parathyroid hormone (PTH) influences bone formation, particularly in the context of osteoporosis, a significant health issue for older adults. The study aims to explore the role of salt inducible kinases (SIKs) as mediators of PTH action in bone cells. By blocking the activity of SIKs, researchers hope to mimic the bone-building effects of PTH without the need for daily injections. The ultimate goal is to develop new oral medications that can effectively stimulate bone formation and improve treatment options for osteoporosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who are at risk for or currently suffering from osteoporosis.
Not a fit: Patients who are not affected by osteoporosis or those who are not in the aging population may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new oral therapies that enhance bone formation and provide a more convenient treatment option for osteoporosis.
How similar studies have performed: Previous research has shown promise in targeting similar pathways for bone health, indicating that this approach could lead to significant advancements in osteoporosis treatment.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Wein, Marc Nathan — Massachusetts General Hospital
- Study coordinator: Wein, Marc Nathan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.